Skip to main content
    T

    Tempest Therapeutics Inc (TPST)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.34
    -0.04 (-10.50%)

    Market Cap: $7.64M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tempest Therapeutics Inc (TPST) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Tempest Therapeutics (TPST) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Tempest Therapeutics reported EPS of -$0.21, above the -$0.32 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    59%(23/39)
    Avg Surprise
    +6.07%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.30
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    TPST has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 39 quarters below that had an estimate, TPST beat 23, missed 15 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2018, when EPS landed 80.49% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.21-$0.32-$0.32 - -$0.32+34.38%BeatN/A11 up, 0 downNov 13, 2026N/A
    Jun 30, 2026-$0.34-$0.30-$0.30 - -$0.30-13.33%MissN/A10 up, 0 downAug 13, 2026N/A
    Mar 31, 2026-$0.50-$0.28-$0.28 - -$0.28-79.96%MissN/A10 up, 0 downMay 14, 2026N/A
    Dec 31, 2025-$0.62-$0.62-$0.62 - -$0.620.00%In lineN/A11 up, 0 downMar 31, 2026N/A
    Sep 30, 2025-$0.79-$3.27-$3.27 - -$3.27+75.84%BeatN/A11 up, 0 downNov 5, 2025N/A
    Jun 30, 2025-$2.07-$3.23-$3.23 - -$3.23+35.91%BeatN/A11 up, 0 downAug 11, 2025N/A
    Mar 31, 2025-$3.16-$3.29-$4.42 - -$2.47+3.95%BeatN/A31 up, 1 downMay 13, 2025N/A
    Dec 31, 2024-$0.31-$0.25-$0.30 - -$0.19-26.53%MissN/A41 up, 0 downMar 27, 2025$486000
    Sep 30, 2024-$5.33-$4.58-$5.20 - -$4.03-16.38%MissN/A50 up, 0 downNov 12, 2024N/A
    Jun 30, 2024-$5.46-$5.33-$7.28 - -$4.29-2.44%MissN/A50 up, 0 downAug 8, 2024N/A
    Mar 31, 2024-$4.68-$4.94-$6.24 - -$4.29+5.26%BeatN/A50 up, 0 downMay 9, 2024N/A
    Dec 31, 2023-$0.38-$0.39-$0.43 - -$0.32+2.56%BeatN/A50 up, 0 downMar 19, 2024N/A
    Sep 30, 2023-$6.24-$7.19-$8.19 - -$6.89+13.21%BeatN/A40 up, 0 downNov 8, 2023N/A
    Jun 30, 2023-$7.02-$7.54-$8.32 - -$4.29+6.90%BeatN/A40 up, 0 downAug 10, 2023N/A
    Mar 31, 2023-$7.15-$8.54-$8.71 - -$7.80+16.28%BeatN/A40 up, 0 downMay 10, 2023N/A
    Dec 31, 2022-$0.63-$0.76-$0.89 - -$0.68+17.11%BeatN/A40 up, 0 downMar 22, 2023N/A
    Sep 30, 2022-$8.58-$9.88-$12.09 - -$9.10+13.16%BeatN/A40 up, 0 downNov 8, 2022N/A
    Jun 30, 2022-$10.27-$12.00N/A+14.42%BeatN/AN/A0 up, 0 downAug 15, 2022N/A
    Mar 31, 2022-$1.18-$1.12-$1.18 - -$1.12-5.36%MissN/A30 up, 1 downMay 13, 2022N/A
    Dec 31, 2021-$7.93-$16.03-$16.51 - -$15.47+50.53%BeatN/A3N/AMar 29, 2022N/A
    Sep 30, 2021-$15.73-$13.61-$14.56 - -$12.35-15.58%MissN/A3N/ANov 10, 2021N/A
    Jun 30, 2021-$13.69-$11.37-$12.22 - -$10.53-20.40%MissN/A2N/AAug 12, 2021N/A
    Mar 31, 2021-$6.60-$5.25N/A-25.71%MissN/AN/AN/AMay 13, 2021N/A
    Dec 31, 2020-$5.85-$5.15N/A-13.59%MissN/AN/AN/AMar 29, 2021N/A
    Sep 30, 2020-$5.10-$6.90N/A+26.09%BeatN/AN/AN/ANov 9, 2020N/A
    Jun 30, 2020-$8.40-$8.20N/A-2.44%MissN/AN/AN/AAug 10, 2020N/A
    Mar 31, 2020-$9.75-$10.00N/A+2.50%BeatN/AN/AN/AMay 8, 2020N/A
    Dec 31, 2019-$13.05-$12.18N/A-7.14%MissN/AN/AN/AMar 11, 2020N/A
    Sep 30, 2019-$13.05-$12.38N/A-5.41%MissN/AN/AN/ANov 13, 2019N/A
    Jun 30, 2019-$11.10-$12.12N/A+8.42%BeatN/AN/AN/AAug 12, 2019N/A
    Mar 31, 2019-$11.70-$10.55N/A-10.90%MissN/AN/AN/AMay 15, 2019N/A
    Dec 31, 2018-$12.30-$12.85N/A+4.28%BeatN/AN/AN/AMar 29, 2019N/A
    Sep 30, 2018-$0.79-$4.05N/A+80.49%BeatN/AN/AN/ANov 9, 2018N/A
    Jun 30, 2018-$3.30-$4.05N/A+18.48%BeatN/AN/AN/AAug 9, 2018N/A
    Mar 31, 2018-$3.15-$0.28N/AN/AN/AN/AN/AN/AMay 3, 2018N/A
    Dec 31, 2017-$54.00-$61.95N/A+12.83%BeatN/AN/AN/AMar 15, 2018N/A
    Sep 30, 2017-$58.50-$89.78N/A+34.84%BeatN/AN/AN/ANov 2, 2017$56000
    Jun 30, 2017-$114.75-$94.33N/A-21.65%MissN/AN/AN/AAug 3, 2017$84000
    Mar 31, 2017-$85.50-$95.96N/A+10.90%BeatN/AN/AN/AMay 9, 2017$63000
    Dec 31, 2016-$110.25-$129.94N/A+15.15%BeatN/AN/AN/AMar 2, 2017$121000
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$6.64, after -$15.78 the year before. It was -$551.25 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$6.64N/A
    Dec 31, 2024-$15.78N/A
    Dec 31, 2023-$20.79N/A
    Dec 31, 2022-$20.66N/A
    Dec 31, 2021-$43.95N/A
    Dec 31, 2020-$29.10N/A
    Dec 31, 2019-$48.90N/A
    Dec 31, 2018-$19.54N/A
    Dec 31, 2017-$312.75N/A
    Dec 31, 2016-$551.25N/A

    Frequently Asked Questions About TPST

    When is Tempest Therapeutics's next earnings date?

    Tempest Therapeutics's next earnings report is expected for Mar 29, 2027.

    Did TPST beat earnings estimates last quarter?

    Yes. Tempest Therapeutics reported EPS of -$0.21 for the quarter ended Sep 30, 2026, above the -$0.32 estimate, a 34.38% surprise.

    What EPS do analysts expect from TPST next quarter?

    The consensus EPS estimate for Tempest Therapeutics for the quarter ending Dec 31, 2026 is -$0.30 from 3 analysts.

    How often does TPST beat earnings estimates?

    Tempest Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +3.78%.